This inventor holds 1 USPTO granted patent. Top assignee: Medivir Ab. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovations of Peter Thomas Lind
Introduction
Peter Thomas Lind is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of chemistry, particularly with his innovative patent related to pharmaceutical compounds. His work has implications for the development of new therapeutic agents.
Latest Patents
Peter Thomas Lind holds a patent for N-arylalkyl-N-heteroarylurea and guanidine compounds and methods of use. This patent represents a key advancement in the search for effective treatments in various medical conditions. His innovative approach has the potential to influence future research and development in the pharmaceutical industry.
Career Highlights
Lind is currently associated with Medivir AB, a company known for its focus on developing innovative medicines for the treatment of viral infections and cancer. His role at Medivir AB allows him to apply his expertise in chemistry to real-world challenges in healthcare.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues such as Rolf Noreen and Robert J. Ternansky. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Peter Thomas Lind's contributions to the field of chemistry and his innovative patent highlight his role as a significant inventor in the pharmaceutical industry. His work continues to inspire advancements in medical research and development.